Abstract
Evidences have been showing that alternative splicing occurs in at least 95% of human genes which increase the proteomic diversity, as 80% of these events occur within the coding region. Some splicing variants are preferentially expressed in human tumors and can be potential molecular markers for more accurate diagnostic and prognostic factors, as well as therapeutic targets. The aim of t…